Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

7 results about "Beta-lactamase" patented technology

Beta-lactamases are enzymes (EC 3.5.2.6) produced by bacteria that provide multi-resistance to β-lactam antibiotics such as penicillins, cephalosporins, cephamycins, and carbapenems (ertapenem), although carbapenems are relatively resistant to beta-lactamase. Beta-lactamase provides antibiotic resistance by breaking the antibiotics' structure. These antibiotics all have a common element in their molecular structure: a four-atom ring known as a β-lactam. Through hydrolysis, the enzyme lactamase breaks the β-lactam ring open, deactivating the molecule's antibacterial properties.

Compound for preparing MBL and / or SBL enzyme inhibitor, application and medicine thereof

The invention provides a compound for preparing an MBL and / or SBL enzyme inhibitor, application of the compound and a medicine of the compound, and belongs to the field of medicine. The structure of the compound is shown as a formula I. The compound provided by the invention has good and broad-spectrum inhibitory activity on clinically common metal beta lactamase (MBL) and serine beta lactamase (SBL), can be used as an MBL and / or SBL enzyme inhibitor, and is used for preparing antibacterial drugs, especially drugs for resisting drug-resistant bacteria. In addition, the compound disclosed by the invention is combined with beta-lactam antibiotic meropenem and the like for use, so that the compound has relatively good antibacterial activity on various beta-lactam antibiotic drug-resistant bacteria. The compound disclosed by the invention has great potential in preparation of MBL and SBL dual broad-spectrum inhibitors and medicines for resisting beta-lactam antibiotic-resistant bacteria. The invention provides a new choice for the use of antibacterial drugs, and has a good application prospect.
Owner:SICHUAN UNIV

Assays and methods for determining microbial resistance

Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple β-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and / or probes for identification of β-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT / MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24 / 40-like, TEM-like, and SHV-like. A kit may also include one or more primers and / or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.
Owner:CREIGHTON UNIVERSITY +1

Composition for detecting acinetobacter baumannii and beta lactamase drug-resistant gene of acinetobacter baumannii

The invention belongs to the field of molecular biological detection, and provides a joint detection composition which is mainly used for detecting acinetobacter baumannii and a drug-resistant gene thereof by utilizing a multiple fluorescent PCR (Polymerase Chain Reaction) analysis method, so that at least four targets in pgaD, NDM, OXA23, OXA24, OXA51 and OXA58 are simultaneously detected and distinguished in a single-tube reaction system. Meanwhile, the detection sensitivity of the composition is higher and reaches 500 copies / mL, and the detection is more accurate.
Owner:SANSURE BIOTECH INC

Thiazole amine-diazabicyclooctanone conjugate derivatives and uses thereof

The application provides a kind of thiazole amine-diazabicyclo octanone conjugate derivative and its use, belong to the field of medicine.The compound provided by the application has good, broad-spectrum inhibitory activity on metal beta lactamase (MBL) and serine beta lactamase (SBL), and can be used for preparing MBL and / or SBL inhibitor.The compound of the application has great potential in preparing MBL and / or SBL inhibitor and antibacterial drug (especially drug for resisting drug-resistant bacteria).
Owner:FUAN PHARM GRP CHONGQING SUNHORIZON PHARM TECH CO LTD

Detection of antibiotic resistance genes

Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple β-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and / or probes for identification of β-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT / MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51 -like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24 / 40-like, TEM-like, SHV-like, and GES-like. A kit may also include one or more primers and / or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.
Owner:STRECK LLC

Detection of Antibiotic Resistance Genes

Assays and methods for detecting resistance to beta-lactam antibiotics including detection of multiple β-lactamase family specific gene targets by polymerase chain reaction or microarray. One or more kits including primers and / or probes for identification of β-lactamase genes selected from the group consisting of one or more of the following: MOX-like, FOX-like, ACC-like, ACT / MIR-like, CMY-2-like, DHA-like, CTX-M-14-like, CTX-M-15-like, VIM-like, NDM-like, IMP-like, KPC-like, and OXA-48-like, OXA-51-like, OXA-143-like, OXA-58-like, OXA-23-like, OXA-24 / 40-like, TEM-like, SHV-like, and GES-like. A kit may also include one or more primers and / or probes for the identification a non-beta lactamase gene family which confers antibiotic resistance, such as the MCR-1 gene.
Owner:STRECK INC +1